← Open Payments lookup

ADAM CASEY: Open Payments

NPI 1548735673 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,904 in 90 payments from 18 companies in 2025. Trend: 2023 $1,086 · 2024 $1,262 · 2025 $1,904

Food & beverage: $1,820Education: $84
CompanyPaymentsAmount
ABBVIE INC.30$500
Madrigal Pharmaceuticals10$357
Janssen Biotech, Inc.8$203
QOL Medical, LLC8$170
Takeda Pharmaceuticals U.S.A., Inc.5$153
Aimmune Therapeutics, Inc.5$100
GENZYME CORPORATION3$69
Ardelyx, Inc.4$63
Novo Nordisk Inc2$59
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$47

Products named: REZDIFFRA, RINVOQ, TREMFYA, Sucraid, EOHILIA, LINZESS, SKYRIZI, DUPIXENT.

Industry payments across NV — which companies pay providers there.